Expression and significance of KAI1/CD82 and E-Cadherin in human squamous cervical carcinoma

Journal of Xi'an Jiaotong University (Medical Sciences)

Volumn 27, Issue 3, 2006, Pages 274-277

  Wang, Guoqing ^a   Li, Mingzhong ^b   Liu, Zi ^b  

^a Hospital of Shaanxi Province   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cervical cancer; E cadherin; Immunohistochemistry; KAI1 CD82; Lymphonode metastasis

Indexed keywords

CD82 ANTIGEN; UVOMORULIN;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM;

EID: 33746104534     PISSN: 16718259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mashimo T, Waabe M, Hirota S, et al. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53 [J]. Proc Natl Acad Sci USA, 1998, 95(19):11307.
2. Jackson P, Grimm MO, Kingsley EA, et al. Relationship between expression of KAI1 m3etastasis suppressor gene, mRNA levers and p53 in human bladder and pristate cancer cell lines [J]. Urol Oncol, 2002, 7(3):99.
3. Maurer CA, Graber HU, Friess H, et al. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases [J]. Surgery, 1999, 126(5):869-880.
4. Hashida H, Takabayashi A, Tokuhara T, et al. Clinical significance of transmembrane 4 superfamily in colon cancer [J]. Br J Cancer, 2003, 89(1):158-167.
5. Muneyuki T, Watanabe M, Yamanaka M, et al. KAI1/CD82 expression as a prognosic factor in sporadic colorectal Cancer [J]. Anticancer Res, 2001, 21(95):3581-3587.
6. Lombardi DP, Geradts J, Foley JF, et al. Loss of KAI1 expression in the progression of colorectal cancer [J]. Cancer Res, 1999, 59(22):5724-5731.
7. Imai Y, Sasaki T, Shinagawa Y, et al. Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance [J]. Oral Oncol, 2002, 38(6):557.
8. Fei Q, Zhang H, Chen X, et al. Defected expression of E-Cadherin in non-small cell lung cancer [J]. Lung Cancer, 2002, 37 (2):147-152.
9. Chen HC, Chu RY, Hsu PN, et al. Loss of E-Cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas [J]. Cancer Letter, 2003, 201(1):97-106.
10. Siitonen SM, Kononen JT, Helin HJ, et al. Reduced E - cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer [J]. Am J Clin Pathol, 1996, 105:394-402.
11. Wahed A, Connelly J, Reese T. E-Cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma [J]. Ann Diagn Pathol; 2002, 6(6):349-351.